Pharmacogenetics (PGx) Medication Search Tool
Medication | Drug Category | Used to treat | Gene(s) | Report type* |
---|---|---|---|---|
Cimetidine | Antihistamine/Antacid | Acid Reflux, Stomach Ulcers | CYP3A | Moderate Inhibitor |
Amphetamine | Psychostimulant | ADHD | CYP2D6 | Genotype Impact |
Atomoxetine | ADHD Medication | ADHD | CYP2D6 | Genotype Impact |
Dexamphetamine / Dextroamphetamine | Psychostimulant | ADHD | CYP2D6 | Genotype Impact |
Lisdexamfetamine | Psychostimulant | ADHD | CYP2D6 | Genotype Impact |
Chlorpheniramine | Antihistamine | Allergies | CYP2D6 | Genotype Impact |
Dexchlorpheniramine | Antihistamine | Allergies | CYP2D6 | Genotype Impact |
Promethazine | Antihistamine | Allergies | CYP2D6 | Genotype Impact |
Montelukast | Anti-Inflammatory | Allergies, Asthma Attacks | CYP1A2 | Inducer |
Perhexiline | Antianginals | Angina (From Ischaemic Heart Disease) | CYP2D6 | Genotype Impact, Strong Inhibitor |
Ethinylestradiol | Oral Contraceptive | Birth Control, Menopausal Symptoms, Gynecological Disorders | CYP1A2 | Moderate Inhibitor |
Acenocoumarol | Anticoagulant (Blood Thinner) | Blood Clots | VKORC1, CYP2C9 | Genotype Impact |
Warfarin | Anticoagulant (Blood Thinner) | Blood Clots | VKORC1, CYP2C9 | Genotype Impact |
Tamoxifen | Estrogen Modulator | Breast Cancer | CYP2D6 | Genotype Impact |
Tetrabenazine | Involuntary Movement Reducer | Chorea (Caused By Huntington Disease) | CYP2D6 | Genotype Impact |
Deutetrabenazine | Neurological Drugs | Chorea (Caused By Huntington Disease), Tardive Dyskinesia | CYP2D6 | Genotype Impact |
Dextromethorphan | Antitussive | Cough Suppressant | CYP2D6 | Genotype Impact |
Agomelatine | Antidepressant | Depression | CYP1A2 | Genotype Impact |
Amitriptyline | Antidepressant - Tricyclic | Depression, Nerve Pain, Migraine | CYP2D6, CYP2C19 | Genotype Impact |
Amoxapine | Antidepressant - Tricyclic | Depression | CYP2D6 | Genotype Impact |
Citalopram | Antidepressant - Ssri | Depression, OCD, panic disorder, social phobia | CYP2C19 | Genotype Impact |
Clomipramine | Antidepressant - Tricyclic | Depression, OCD, panic disorder, chronic pain, nerve pain | CYP2D6, CYP2C19 | Genotype Impact |
Desipramine | Antidepressant - Tricyclic | Depression, Nerve Pain | CYP2D6 | Genotype Impact |
Dothiepin / Dosulepin | Antidepressant - Tricyclic | Depression | CYP2D6, CYP2C19 | Genotype Impact |
Doxepin | Antidepressant - Tricyclic | Depression, Nerve Pain | CYP2D6, CYP2C19 | Genotype Impact |
Duloxetine | Antidepressant - Snri | Depression, Anxiety, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscle/Bone Pain | CYP2D6, CYP1A2 | Genotype Impact |
Escitalopram | Antidepressant - Ssri | Depression, Generalized Anxiety Disorder | CYP2C19 | Genotype Impact |
Fluoxetine | Antidepressant - Ssri | Depression, OCD, bulimia nervosa, panic disorder | CYP2D6, CYP2C9 / CYP2C19 / CYP2D6 | Genotype Impact / Moderate Inhibitor / Strong Inhibitor |
Fluvoxamine | Antidepressant - Ssri | Depression, OCD | CYP2D6, CYP1A2 / CYP1A2, CYP2C19 / CYP3A | Genotype Impact / Strong Inhibitor / Moderate Inhibitor |
Imipramine | Antidepressant - Tricyclic | Depression, Nerve Pain, Anxiety, Panic Disorder | CYP2D6, CYP2C19 | Genotype Impact |
Mianserin | Antidepressant | Depression | CYP2D6 | Genotype Impact |
Mirtazapine | Antidepressant | Depression | CYP2D6, CYP1A2 | Genotype Impact |
Moclobemide | Antidepressant | Depression, Social Anxiety | CYP2C19 / CYP2D6 | Genotype Impact, Moderate Inhibitor / Moderate Inhibitor |
Nortriptyline | Antidepressant - Tricyclic | Depression, Nerve Pain, Anxiety | CYP2D6 | Genotype Impact |
Paroxetine | Antidepressant - Ssri | Depression, anxiety, OCD, premenstrual dysmorphic disorder | CYP2D6 | Genotype Impact, Strong Inhibitor |
Protriptyline | Antidepressant - Tricyclic | Depression, Nerve Pain, Migraine | CYP2D6 | Genotype Impact |
Trimipramine | Antidepressant - Tricyclic | Depression, Nerve Pain, Myelodysplastic Syndrome | CYP2D6, CYP2C19 | Genotype Impact |
Venlafaxine | Antidepressant - Snri | Depression, Nerve Pain, Generalized Anxiety Disorder, Panic Disorder, And Social Anxiety | CYP2D6 | Genotype Impact |
Vortioxetine | Antidepressant | Depression | CYP2D6 | Genotype Impact |
Duloxetine | Antidepressant/Nerve Pain Medication | Depression, Anxiety, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscle/Bone Pain | CYP2D6 | Moderate Inhibitor |
Doxepin | Antidepressant/Nerve Pain Medication | Depression, Anxiety, Sleep Disorders | CYP2D6 | Moderate Inhibitor |
Sertraline | Antidepressant - Ssri | Depression, OCD, PTSD, anxiety, panic disorder | CYP2C19 | Genotype Impact |
Brexpiprazole | Antipsychotic | Depression, Schizophrenia | CYP2D6 | Genotype Impact |
Quetiapine | Antipsychotic | Depression, Schizophrenia, Bipolar Disorder | CYP3A4 | Genotype Impact |
Bupropion | Antidepressant | Depression, Smoking Cessation | CYP2D6 | Strong Inhibitor |
Clarithromycin | Antibiotic | Duodenal Ulcers (Caused By H. Pylori), Prevent Infections | CYP3A | Strong Inhibitor |
Tamsulosin | Urinary Retention | Enlarged Prostate | CYP2D6 | Genotype Impact |
Armodafinil | Stimulant | Excessive Sleepiness | CYP3A | Inducer |
Modafinil | Stimulant | Excessive Sleepiness | CYP3A | Inducer |
Fluconazole | Antifungal | Fungal Infections | CYP2C9 / CYP2C19 / CYP3A | Moderate Inhibitor / Strong Inhibitor / Moderate Inhibitor |
Itraconazole | Antifungal | Fungal Infections | CYP3A | Strong Inhibitor |
Miconazole | Antifungal | Fungal Infections | CYP2C9 | Moderate Inhibitor |
Posaconazole | Antifungal | Fungal Infections | CYP3A | Strong Inhibitor |
Terbinafine | Antifungals | Fungal Infections | CYP2D6 | Moderate Inhibitor |
Voriconazole | Antifungals- Azoles | Fungal Infections | CYP2C19 / CYP3A | Genotype Impact, Moderate Inhibitor / Strong Inhibitor |
Eliglustat | Gaucher Disease Treatment | Gaucher Disease (Genetic Condition) | CYP2D6 | Genotype Impact |
Metoclopramide | Antiemetic | GERD, gastroparesis in diabetes | CYP2D6 | Genotype Impact |
Dexlansoprazole | Proton Pump Inhibitor | Heartburn, Gerd, Esophageal Damage | CYP2C19 | Genotype Impact |
Esomeprazole | Proton Pump Inhibitor | Heartburn, Gerd, Esophageal Damage | CYP2C19 | Genotype Impact, Moderate Inhibitor |
Lansoprazole | Proton Pump Inhibitor | Heartburn, Gerd, Esophageal Damage | CYP2C19 | Genotype Impact |
Omeprazole | Proton Pump Inhibitor | Heartburn, Gerd, Esophageal Damage | CYP2C19 / CYP1A2 | Genotype Impact, Moderate Inhibitor / Inducer |
Pantoprazole | Proton Pump Inhibitor | Heartburn, Gerd, Esophageal Damage | CYP2C19 | Genotype Impact |
Rabeprazole | Proton Pump Inhibitor | Heartburn, Gerd, Esophageal Damage | CYP2C19 | Genotype Impact |
Asunepravir | Experimental | Hepatitis C | CYP2D6 | Moderate Inhibitor |
Bocepravir | Protease Inhibitor | Hepatitis C | CYP3A | Strong Inhibitor |
Irbesartan | Angiotensin Receptor Blocker | High Blood Pressure | CYP2C9 | Genotype Impact |
Losartan | Angiotensin Receptor Blocker | High Blood Pressure | CYP2C9 | Genotype Impact |
Diltiazem | Antihypertensive/Calcium Blocker | High Blood Pressure, Angina | CYP3A | Moderate Inhibitor |
Verapamil | Antihypertensive/Calcium Blocker | High Blood Pressure, Angina, Arrhythmia | CYP3A | Moderate Inhibitor |
Carvedilol | Beta Blocker | High Blood Pressure, Heart Failure | CYP2D6 | Genotype Impact |
Metoprolol | Beta Blocker | High Blood Pressure, Heart Failure | CYP2D6 | Genotype Impact |
Nebivolol | Beta Blocker | High Blood Pressure, Heart Failure | CYP2D6 | Genotype Impact |
Propranolol | Beta Blocker | High Blood Pressure, Heart Failure | CYP2D6, CYP1A2 | Genotype Impact |
Timolol | Beta Blocker | High Blood Pressure, Migraine, Glaucoma/Ocular Hypertension | CYP2D6 | Genotype Impact |
Lesinurad | Urate Transporter Inhibitor | High Blood Uric Acid | CYP2C9 | Genotype Impact |
Atorvastatin | Statin | High Cholesterol | SLCO1B1, CYP3A4 | Genotype Impact |
Fluvastatin | Statin | High Cholesterol | SLCO1B1, CYP2C9 | Genotype Impact |
Pravastatin | Statin | High Cholesterol | SLCO1B1 | Genotype Impact |
Rosuvastatin | Statin | High Cholesterol | SLCO1B1 | Genotype Impact |
Simvastatin | Statin | High Cholesterol | SLCO1B1, CYP3A4 | Genotype Impact |
Atazanavir | Antiviral | HIV | CYP3A5 / CYP3A | Genotype Impact / Moderate Inhibitor |
Cobicistat | Antiviral | HIV | CYP3A | Strong Inhibitor |
Darunavir/Ritonavir | Antiviral | HIV | CYP3A | Strong Inhibitor |
Efavirenz | Antiviral | HIV | CYP2B6 / CYP2C19, CYP3A, CYP2B6 | Genotype Impact / Inducer |
Etravirine | Antiviral | HIV | CYP3A | Inducer |
Fosamprenavir | Antiviral | HIV | CYP3A | Moderate Inhibitor |
Indinavir | Antiviral | HIV | CYP3A | Strong Inhibitor |
Lopinavir/Ritonavir | Antiviral | HIV | CYP2C19 / CYP3A | Inducer / Strong Inhibitor |
Nevirapine | Antiviral | HIV | CYP2B6 / CYP3A | Genotype Impact / Inducer |
Ritonavir | Antiviral | HIV | CYP2B6 / CYP2D6 / CYP3A | Inducer / Moderate Inhibitor / Strong Inhibitor |
Saquinavir | Antiviral | HIV | CYP3A | Strong Inhibitor |
Tipranavir | Antiviral | HIV | CYP2D6 | Moderate Inhibitor |
Tipranavir / Ritonavir | Antiviral | HIV | CYP3A / CYP2C19 | Strong Inhibitor / Inducer |
Cinacalcet | Calcium Reducer | Hypercalcemia | CYP2D6 | Moderate Inhibitor |
Conivaptan | Aquaretic | Hyponatremia | CYP3A | Strong Inhibitor |
Ciprofloxacin | Antibiotic | Infections | CYP1A2 / CYP3A | Strong Inhibitor / Moderate Inhibitor |
Erythromycin | Antibiotics/Gut Motility Stimulator | Infections | CYP3A | Moderate Inhibitor |
Dexamethasone | Corticosteroid | Inflammation | CYP3A | Inducer |
Melatonin | Hypnotics | Insomnia | CYP1A2 | Genotype Impact |
Amiodarone | Antiarrhythmics | Irregular Heartbeat | CYP2C9 | Moderate Inhibitor |
Flecainide | Antiarrhythmics | Irregular Heartbeat | CYP2D6 | Genotype Impact, Moderate Inhibitor |
Propafenone | Antiarrhythmics | Irregular Heartbeat | CYP2D6 | Genotype Impact |
Risperidone | Antipsychotic | Irritability Associated With Autism; Schizophrenia, Bipolar Disorder | CYP2D6 | Genotype Impact |
Aripiprazole | Antipsychotic | Irritability Associated With Autism; Schizophrenia, Bipolar Disorder, Depression, Symptoms Of Tourette Syndrome | CYP2D6 | Genotype Impact |
Imatinib | Chemotherapy | Leukema And Other Cancers | CYP3A | Moderate Inhibitor |
Cyclophosphamide | Immunosuppressant/Chemotherapy | Leukemia, Lymphomas, Nephrotic Syndrome | CYP2C19 | Genotype Impact |
Proguanil | Antimalarial | Malaria | CYP2C19 | Genotype Impact |
Quinine | Antimalarial | Malaria | CYP2D6 | Moderate Inhibitor |
Vemuranfenib | Chemotherapy | Melanoma | CYP1A2 | Moderate Inhibitor |
Dabrafenib | Chemotherapy | Melanoma, Braf-Mutated Cancers | CYP3A | Inducer |
Olanzapine | Antipsychotic | Mental Disorders, Schizophrenia, And Bipolar Disorder | CYP1A2 | Genotype Impact |
Haloperidol | Antipsychotic | Mental Disorders, Symptoms Of Tourette Syndrome | CYP2D6 | Genotype Impact |
Chlorpromazine | Antipsychotic | Mental Illness, Behavioral Disorders, Nausea/Vomiting | CYP2D6 | Genotype Impact |
Carisoprodol | Neurological Drugs | Muscle Relaxant | CYP2C19 | Genotype Impact |
Aprepitant | Antinausea/Antiemetic | Nausea, Vomiting | CYP3A | Moderate Inhibitor |
Ondansetron | Antiemetic | Nausea, Vomiting | CYP2D6 | Genotype Impact |
Tropisetron | Antiemetic | Nausea, Vomiting | CYP2D6 | Genotype Impact |
Dronabinol | Antiemetic/Orexigenic | Nausea, Vomiting / Loss Of Appetite, Weight Loss | CYP2C9 | Genotype Impact |
Crizotinib | Chemotherapy | Non-Small Cell Lung Cancer | CYP3A | Moderate Inhibitor |
Darifenacin | Anticholinergics/Gu | Overactive Bladder | CYP2D6 | Genotype Impact |
Donepezil | Anticholinesterases | Overactive Bladder | CYP2D6 | Genotype Impact |
Fesoterodine | Anticholinergics/Gu | Overactive Bladder | CYP2D6 | Genotype Impact |
Galantamine | Anticholinesterases | Overactive Bladder | CYP2D6 | Genotype Impact |
Mirabegron | Overactive Bladder | Overactive Bladder | CYP2D6 | Genotype Impact, Moderate Inhibitor |
Tolterodine | Anticholinergics/Gu | Overactive Bladder | CYP2D6 | Genotype Impact |
Celecoxib | Nsaids | Pain | CYP2C9 | Genotype Impact |
Diclofenac | Nsaids | Pain | CYP2C9 | Genotype Impact |
Flurbiprofen | Nsaids | Pain | CYP2C9 | Genotype Impact |
Hydrocodone | Opioid Analgesic | Pain | CYP2D6 | Genotype Impact |
Ibuprofen | Nsaids | Pain | CYP2C9 | Genotype Impact |
Indomethacin | Nsaids | Pain | CYP2C9 | Genotype Impact |
Mefenamic Acid | Nsaids | Pain | CYP2C9 | Genotype Impact |
Meloxicam | Nsaids | Pain | CYP2C9 | Genotype Impact |
Methadone | Opoid Analgesics | Pain | CYP2B6 | Genotype Impact |
Morphine | Opoid Analgesics | Pain | OPRM1, COMT | Genotype Impact |
Oxycodone | Opioid Analgesic | Pain | CYP2D6 | Genotype Impact |
Piroxicam | Nsaids | Pain | CYP2C9 | Genotype Impact |
Tramadol | Opioid Analgesic | Pain | CYP2D6 | Genotype Impact |
Codeine | Narcotic | Pain, Cough | CYP2D6, OPRM1 | Genotype Impact |
Tacrolimus | Immunosuppressive | Prevent Organ Rejection Post-Transplant | CYP3A5 | Genotype Impact |
Cyclosporin | Immunosupressive | Prevent Organ Rejection Post-Transplant, Rheumatoid Arthritis, Psoriasis, Chronic Dry Eye | CYP3A | Moderate Inhibitor |
Clopidogrel | Antiplatelet Drug (Blood Thinner) | Prevention Of Stroke, Heart Attack | CYP2C19 | Genotype Impact |
Ticlopidine | Antiplatelet Drug (Blood Thinner) | Prevention Of Stroke, Heart Attack | CYP2C19 | Strong Inhibitor |
Abiraterone | Chemotherapy | Prostate Cancer | CYP2D6 | Moderate Inhibitor |
Enzalutamide | Nonsteroidal Antiandrogen | Prostate Cancer | CYP2C9, CYP2C19, CYP3A | Inducer |
Bosentan | Dual Endothelin Receptor Antagonist | Pulmonary Artery Hypertension | CYP3A | Inducer |
Naltrexone | Alcohol/Drug Dependence | Relapse Prevention | OPRM1 | Genotype Impact |
Clozapine | Antipsychotic | Schizophrenia | CYP1A2 | Genotype Impact |
Iloperidone | Antipsychotic | Schizophrenia | CYP2D6 | Genotype Impact |
Thioridazine | Antipsychotic | Schizophrenia | CYP2D6 | Genotype Impact |
Perphenazine | Antipsychotic | Schizophrenia, Nausea/Vomiting | CYP2D6 | Genotype Impact |
Zuclopenthixol | Antipsychotic | Schizophrenia, Psychoses | CYP2D6 | Genotype Impact |
Brivaracetam | Antiepileptic/Anticonvulsant | Seizures/Epilepsy | CYP2C19 | Genotype Impact |
Carbamazepine | Antiepileptic/Anticonvulsant | Seizures/Epilepsy | CYP2C9, CYP2C19, CYP3A, CYP2B6 | Inducer |
Clobazam | Benzodiazepine | Seizures/Epilepsy | CYP2C19 | Genotype Impact |
Lacosamide | Antiepileptic/Anticonvulsant | Seizures/Epilepsy | CYP2C19 | Genotype Impact |
Phenobarbitone / Phenobarbital | Antiepileptic/Anticonvulsant | Seizures/Epilepsy | CYP1A2, CYP2C9, CYP3A | Inducer |
Phenytoin | Antiepileptic/Anticonvulsant | Seizures/Epilepsy | CYP2C9 / CYP1A2, CYP3A | Genotype Impact, Inducer / Inducer |
Primidone | Antiepileptic/Anticonvulsant | Seizures/Epilepsy | CYP1A2, CYP2C9, CYP3A | Inducer |
Diazepam | Benzodiazepine | Seizures/Epilepsy, Anxiety, Muscle Spasms | CYP2C19 | Genotype Impact |
Dapoxetine | Sexual Dysfunction | Sexual Dysfunction | CYP2D6 | Genotype Impact |
Flibanserin | Sexual Dysfunction | Sexual Dysfunction | CYP2C19 | Genotype Impact |
Pimozide | Antipsychotic | Symptoms Of Tourette Syndrome | CYP2D6 | Genotype Impact |
Valbenazine | Neurological Drugs | Tardive Dyskinesia | CYP2D6 | Genotype Impact |
Rifampicin | Antibiotic | Tuberculosis | CYP1A2, CYP2C9, CYP2C19, CYP3A, CYP2B6 | Inducer |
Rifabutin | Antibiotic | Tuberculosis And Mycobacterium Avium Complex Prevention | CYP2C9, CYP2C19, CYP3A | Inducer |
Glibenclamide | Antidiabetic | Type 2 Diabetes | CYP2C9 | Genotype Impact |
Gliclazide | Antidiabetic | Type 2 Diabetes | CYP2C9, CYP2C19 | Genotype Impact |
Glimepiride | Antidiabetic | Type 2 Diabetes | CYP2C9 | Genotype Impact |
Glipizide | Antidiabetic | Type 2 Diabetes | CYP2C9 | Genotype Impact |
Glyburide | Antidiabetic | Type 2 Diabetes | CYP2C9 | Genotype Impact |
Medication Sort | Gene(s) Sort | Action | |
---|---|---|---|
Cimetidine | CYP3A | View more Info | |
More InformationDrug Category: Antihistamine/Antacid Used to treat: ADHD Report type*: Moderate Inhibitor |
|||
Amphetamine | CYP2D6 | View more Info | |
More InformationDrug Category: Psychostimulant Used to treat: ADHD Report type*: Genotype Impact |
|||
Atomoxetine | CYP2D6 | View more Info | |
More InformationDrug Category: ADHD Medication Used to treat: ADHD Report type*: Genotype Impact |
|||
Dexamphetamine / Dextroamphetamine | CYP2D6 | View more Info | |
More InformationDrug Category: Psychostimulant Used to treat: ADHD Report type*: Genotype Impact |
|||
Lisdexamfetamine | CYP2D6 | View more Info | |
More InformationDrug Category: Psychostimulant Used to treat: ADHD Report type*: Genotype Impact |
|||
Chlorpheniramine | CYP2D6 | View more Info | |
More InformationDrug Category: Antihistamine Used to treat: Allergies Report type*: Genotype Impact |
|||
Dexchlorpheniramine | CYP2D6 | View more Info | |
More InformationDrug Category: Antihistamine Used to treat: Allergies Report type*: Genotype Impact |
|||
Promethazine | CYP2D6 | View more Info | |
More InformationDrug Category: Antihistamine Used to treat: Allergies Report type*: Genotype Impact |
|||
Montelukast | CYP1A2 | View more Info | |
More InformationDrug Category: Anti-Inflammatory Used to treat: Allergies, Asthma Attacks Report type*: Inducer |
|||
Perhexiline | CYP2D6 | View more Info | |
More InformationDrug Category: Antianginals Used to treat: Angina (From Ischaemic Heart Disease) Report type*: Genotype Impact, Strong Inhibitor |
|||
Ethinylestradiol | CYP1A2 | View more Info | |
More InformationDrug Category: Oral Contraceptive Used to treat: Birth Control, Menopausal Symptoms, Gynecological Disorders Report type*: Moderate Inhibitor |
|||
Acenocoumarol | VKORC1, CYP2C9 | View more Info | |
More InformationDrug Category: Anticoagulant (Blood Thinner) Used to treat: Blood Clots Report type*: Genotype Impact |
|||
Warfarin | VKORC1, CYP2C9 | View more Info | |
More InformationDrug Category: Anticoagulant (Blood Thinner) Used to treat: Blood Clots Report type*: Genotype Impact |
|||
Tamoxifen | CYP2D6 | View more Info | |
More InformationDrug Category: Estrogen Modulator Used to treat: Breast Cancer Report type*: Genotype Impact |
|||
Tetrabenazine | CYP2D6 | View more Info | |
More InformationDrug Category: Involuntary Movement Reducer Used to treat: Chorea (Caused By Huntington Disease) Report type*: Genotype Impact |
|||
Deutetrabenazine | CYP2D6 | View more Info | |
More InformationDrug Category: Neurological Drugs Used to treat: Chorea (Caused By Huntington Disease), Tardive Dyskinesia Report type*: Genotype Impact |
|||
Dextromethorphan | CYP2D6 | View more Info | |
More InformationDrug Category: Antitussive Used to treat: Cough Suppressant Report type*: Genotype Impact |
|||
Agomelatine | CYP1A2 | View more Info | |
More InformationDrug Category: Antidepressant Used to treat: Depression Report type*: Genotype Impact |
|||
Amitriptyline | CYP2D6, CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression, Nerve Pain, Migraine Report type*: Genotype Impact |
|||
Amoxapine | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression Report type*: Genotype Impact |
|||
Citalopram | CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Ssri Used to treat: Depression, OCD, panic disorder, social phobia Report type*: Genotype Impact |
|||
Clomipramine | CYP2D6, CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression, OCD, panic disorder, chronic pain, nerve pain Report type*: Genotype Impact |
|||
Desipramine | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression, Nerve Pain Report type*: Genotype Impact |
|||
Dothiepin / Dosulepin | CYP2D6, CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression Report type*: Genotype Impact |
|||
Doxepin | CYP2D6, CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression, Nerve Pain Report type*: Genotype Impact |
|||
Duloxetine | CYP2D6, CYP1A2 | View more Info | |
More InformationDrug Category: Antidepressant - Snri Used to treat: Depression, Anxiety, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscle/Bone Pain Report type*: Genotype Impact |
|||
Escitalopram | CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Snri Used to treat: Depression, Generalized Anxiety Disorder Report type*: Genotype Impact |
|||
Fluoxetine | CYP2D6, CYP2C9 / CYP2C19 / CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant - Ssri Used to treat: Depression, OCD, bulimia nervosa, panic disorder Report type*: Genotype Impact / Moderate Inhibitor / Strong Inhibitor |
|||
Fluvoxamine | CYP2D6, CYP1A2 / CYP1A2, CYP2C19 / CYP3A | View more Info | |
More InformationDrug Category: Antidepressant - Ssri Used to treat: Depression, OCD Report type*: Genotype Impact / Strong Inhibitor / Moderate Inhibitor |
|||
Imipramine | CYP2D6, CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression, Nerve Pain, Anxiety, Panic Disorder Report type*: Genotype Impact |
|||
Mianserin | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant Used to treat: Depression Report type*: Genotype Impact |
|||
Mirtazapine | CYP2D6, CYP1A2 | View more Info | |
More InformationDrug Category: Antidepressant Used to treat: Depression Report type*: Genotype Impact |
|||
Moclobemide | CYP2C19 / CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant Used to treat: Depression, Social Anxiety Report type*: Genotype Impact, Moderate Inhibitor / Moderate Inhibitor |
|||
Nortriptyline | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression, Nerve Pain, Anxiety Report type*: Genotype Impact |
|||
Paroxetine | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant - Ssri Used to treat: Depression, anxiety, OCD, premenstrual dysmorphic disorder Report type*: Genotype Impact, Strong Inhibitor |
|||
Protriptyline | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression, Nerve Pain, Migraine Report type*: Genotype Impact |
|||
Trimipramine | CYP2D6, CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Tricyclic Used to treat: Depression, Nerve Pain, Myelodysplastic Syndrome Report type*: Genotype Impact |
|||
Venlafaxine | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant - Snri Used to treat: Depression, Nerve Pain, Generalized Anxiety Disorder, Panic Disorder, And Social Anxiety Report type*: Genotype Impact |
|||
Vortioxetine | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant Used to treat: Depression Report type*: Genotype Impact |
|||
Duloxetine | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant/Nerve Pain Medication Used to treat: Depression, Anxiety, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscle/Bone Pain Report type*: Moderate Inhibitor |
|||
Doxepin | CYP2D6 | View more Info | |
More InformationDrug Category: Antidepressant/Nerve Pain Medication Used to treat: Depression, Anxiety, Sleep Disorders Report type*: Moderate Inhibitor |
|||
Sertraline | CYP2C19 | View more Info | |
More InformationDrug Category: Antidepressant - Ssri Used to treat: Depression, OCD, PTSD, anxiety, panic disorder Report type*: Genotype Impact |
|||
Brexpiprazole | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Depression, Schizophrenia Report type*: Genotype Impact |
|||
Quetiapine | CYP3A4 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Depression, Schizophrenia, Bipolar Disorder Report type*: Genotype Impact |
|||
Bupropion | CYP3A4 | View more Info | |
More InformationDrug Category: Antidepressant Used to treat: Depression, Smoking Cessation Report type*: Strong Inhibitor |
|||
Clarithromycin | CYP3A | View more Info | |
More InformationDrug Category: Antibiotic Used to treat: Duodenal Ulcers (Caused By H. Pylori), Prevent Infections Report type*: Strong Inhibitor |
|||
Tamsulosin | CYP2D6 | View more Info | |
More InformationDrug Category: Urinary Retention Used to treat: Enlarged Prostate Report type*: Genotype Impact |
|||
Armodafinil | CYP3A | View more Info | |
More InformationDrug Category: Stimulant Used to treat: Excessive Sleepiness Report type*: Inducer |
|||
Modafinil | CYP3A | View more Info | |
More InformationDrug Category: Stimulant Used to treat: Excessive Sleepiness Report type*: Inducer |
|||
Fluconazole | CYP2C9 / CYP2C19 / CYP3A | View more Info | |
More InformationDrug Category: Antifungal Used to treat: Fungal Infections Report type*: Moderate Inhibitor / Strong Inhibitor / Moderate Inhibitor |
|||
Itraconazole | CYP3A | View more Info | |
More InformationDrug Category: Antifungal Used to treat: Fungal Infections Report type*: Strong Inhibitor |
|||
Miconazole | CYP2C9 | View more Info | |
More InformationDrug Category: Antifungal Used to treat: Fungal Infections Report type*: Moderate Inhibitor |
|||
Posaconazole | CYP3A | View more Info | |
More InformationDrug Category: Antifungal Used to treat: Fungal Infections Report type*: Strong Inhibitor |
|||
Terbinafine | CYP2D6 | View more Info | |
More InformationDrug Category: Antifungal Used to treat: Fungal Infections Report type*: Moderate Inhibitor |
|||
Voriconazole | CYP2C19 / CYP3A | View more Info | |
More InformationDrug Category: Antifungals- Azoles Used to treat: Fungal Infections Report type*: Genotype Impact, Moderate Inhibitor / Strong Inhibitor |
|||
Eliglustat | CYP2D6 | View more Info | |
More InformationDrug Category: Gaucher Disease Treatment Used to treat: Gaucher Disease (Genetic Condition) Report type*: Genotype Impact |
|||
Metoclopramide | CYP2D6 | View more Info | |
More InformationDrug Category: Antiemetic Used to treat: GERD, gastroparesis in diabetes Report type*: Genotype Impact |
|||
Dexlansoprazole | CYP2C19 | View more Info | |
More InformationDrug Category: Proton Pump Inhibitor Used to treat: Heartburn, Gerd, Esophageal Damage Report type*: Genotype Impact |
|||
Esomeprazole | CYP2C19 | View more Info | |
More InformationDrug Category: Proton Pump Inhibitor Used to treat: Heartburn, Gerd, Esophageal Damage Report type*: Genotype Impact, Moderate Inhibitor |
|||
Lansoprazole | CYP2C19 | View more Info | |
More InformationDrug Category: Proton Pump Inhibitor Used to treat: Heartburn, Gerd, Esophageal Damage Report type*: Genotype Impact |
|||
Lansoprazole | CYP2C19 | View more Info | |
More InformationDrug Category: Proton Pump Inhibitor Used to treat: Heartburn, Gerd, Esophageal Damage Report type*: Genotype Impact |
|||
Omeprazole | CYP2C19 / CYP1A2 | View more Info | |
More InformationDrug Category: Proton Pump Inhibitor Used to treat: Heartburn, Gerd, Esophageal Damage Report type*: Genotype Impact, Moderate Inhibitor / Inducer |
|||
Pantoprazole | CYP2C19 | View more Info | |
More InformationDrug Category: Proton Pump Inhibitor Used to treat: Heartburn, Gerd, Esophageal Damage Report type*: Genotype Impact |
|||
Rabeprazole | CYP2C19 | View more Info | |
More InformationDrug Category: Proton Pump Inhibitor Used to treat: Heartburn, Gerd, Esophageal Damage Report type*: Genotype Impact |
|||
Asunepravir | CYP2D6 | View more Info | |
More InformationDrug Category: Experimental Used to treat: Hepatitis C Report type*: Moderate Inhibitor |
|||
Bocepravir | CYP3A | View more Info | |
More InformationDrug Category: Protease Inhibitor Used to treat: Hepatitis C Report type*: Strong Inhibitor |
|||
Irbesartan | CYP2C9 | View more Info | |
More InformationDrug Category: Angiotensin Receptor Blocker Used to treat: High Blood Pressure Report type*: Genotype Impact |
|||
Losartan | CYP2C9 | View more Info | |
More InformationDrug Category: Angiotensin Receptor Blocker Used to treat: High Blood Pressure Report type*: Genotype Impact |
|||
Diltiazem | CYP3A | View more Info | |
More InformationDrug Category: Antihypertensive/Calcium Blocker Used to treat: High Blood Pressure, Angina Report type*: Moderate Inhibitor |
|||
Verapamil | CYP3A | View more Info | |
More InformationDrug Category: Antihypertensive/Calcium Blocker Used to treat: High Blood Pressure, Angina, Arrhythmia Report type*: Moderate Inhibitor |
|||
Carvedilol | CYP2D6 | View more Info | |
More InformationDrug Category: Beta Blocker Used to treat: High Blood Pressure, Heart Failure Report type*: Genotype Impact |
|||
Metoprolol | CYP2D6 | View more Info | |
More InformationDrug Category: Beta Blocker Used to treat: High Blood Pressure, Heart Failure Report type*: Genotype Impact |
|||
Nebivolol | CYP2D6 | View more Info | |
More InformationDrug Category: Beta Blocker Used to treat: High Blood Pressure, Heart Failure Report type*: Genotype Impact |
|||
Propranolol | CYP2D6, CYP1A2 | View more Info | |
More InformationDrug Category: Beta Blocker Used to treat: High Blood Pressure, Heart Failure Report type*: Genotype Impact |
|||
Timolol | CYP2D6 | View more Info | |
More InformationDrug Category: Beta Blocker Used to treat: High Blood Pressure, Migraine, Glaucoma/Ocular Hypertension Report type*: Genotype Impact |
|||
Lesinurad | CYP2C9 | View more Info | |
More InformationDrug Category: Urate Transporter Inhibitor Used to treat: High Blood Uric Acid Report type*: Genotype Impact |
|||
Atorvastatin | SLCO1B1, CYP3A4 | View more Info | |
More InformationDrug Category: Statin Used to treat: High Cholesterol Report type*: Genotype Impact |
|||
Fluvastatin | SLCO1B1, CYP3A4 | View more Info | |
More InformationDrug Category: Statin Used to treat: High Cholesterol Report type*: Genotype Impact |
|||
Pravastatin | SLCO1B1 | View more Info | |
More InformationDrug Category: Statin Used to treat: High Cholesterol Report type*: Genotype Impact |
|||
Rosuvastatin | SLCO1B1 | View more Info | |
More InformationDrug Category: Statin Used to treat: High Cholesterol Report type*: Genotype Impact |
|||
Simvastatin | SLCO1B1, CYP3A4 | View more Info | |
More InformationDrug Category: Statin Used to treat: High Cholesterol Report type*: Genotype Impact |
|||
Atazanavir | CYP3A5 / CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Genotype Impact / Moderate Inhibitor |
|||
Cobicistat | CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Strong Inhibitor |
|||
Darunavir/Ritonavir | CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Strong Inhibitor |
|||
Efavirenz | CYP2B6 / CYP2C19, CYP3A, CYP2B6 | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Genotype Impact / Inducer |
|||
Etravirine | CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Inducer |
|||
Fosamprenavir | CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Moderate Inhibitor |
|||
Indinavir | CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Strong Inhibitor |
|||
Lopinavir / Ritonavir | CYP2C19 / CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Inducer / Strong Inhibitor |
|||
Nevirapine | CYP2B6 / CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Genotype Impact / Inducer |
|||
Ritonavir | CYP2B6 / CYP2D6 / CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Inducer / Moderate Inhibitor / Strong Inhibitor |
|||
Saquinavir | CYP3A | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Strong Inhibitor |
|||
Tipranavir | CYP2D6 | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Moderate Inhibitor |
|||
Tipranavir / Ritonavir | CYP3A / CYP2C19 | View more Info | |
More InformationDrug Category: Antiviral Used to treat: HIV Report type*: Strong Inhibitor / Inducer |
|||
Cinacalcet | CYP2D6 | View more Info | |
More InformationDrug Category: Calcium Reducer Used to treat: Hypercalcemia Report type*: Moderate Inhibitor |
|||
Conivaptan | CYP3A | View more Info | |
More InformationDrug Category: Aquaretic Used to treat: Hyponatremia Report type*: Strong Inhibitor |
|||
Ciprofloxacin | CYP1A2 / CYP3A | View more Info | |
More InformationDrug Category: Antibiotic Used to treat: Infections Report type*: Strong Inhibitor / Moderate Inhibitor |
|||
Erythromycin | CYP3A | View more Info | |
More InformationDrug Category: Antibiotics/Gut Motility Stimulator Used to treat: Infections Report type*: Moderate Inhibitor |
|||
Dexamethasone | CYP3A | View more Info | |
More InformationDrug Category: Corticosteroid Used to treat: Inflammation Report type*: Inducer |
|||
Melatonin | CYP1A2 | View more Info | |
More InformationDrug Category: Hypnotics Used to treat: Insomnia Report type*: Genotype Impact |
|||
Amiodarone | CYP2C9 | View more Info | |
More InformationDrug Category: Antiarrhythmics Used to treat: Irregular Heartbeat Report type*: Moderate Inhibitor |
|||
Flecainide | CYP2D6 | View more Info | |
More InformationDrug Category: Antiarrhythmics Used to treat: Irregular Heartbeat Report type*: Genotype Impact, Moderate Inhibitor |
|||
Propafenone | CYP2D6 | View more Info | |
More InformationDrug Category: Antiarrhythmics Used to treat: Irregular Heartbeat Report type*: Genotype Impact |
|||
Risperidone | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Irritability Associated With Autism; Schizophrenia, Bipolar Disorder Report type*: Genotype Impact |
|||
Aripiprazole | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Irritability Associated With Autism; Schizophrenia, Bipolar Disorder, Depression, Symptoms Of Tourette Syndrome Report type*: Genotype Impact |
|||
Imatinib | CYP3A | View more Info | |
More InformationDrug Category: Chemotherapy Used to treat: Leukema And Other Cancers Report type*: Moderate Inhibitor |
|||
Cyclophosphamide | CYP2C19 | View more Info | |
More InformationDrug Category: Immunosuppressant/Chemotherapy Used to treat: Leukemia, Lymphomas, Nephrotic Syndrome Report type*: Genotype Impact |
|||
Proguanil | CYP2C19 | View more Info | |
More InformationDrug Category: Antimalarial Used to treat: Malaria Report type*: Genotype Impact |
|||
Quinine | CYP2D6 | View more Info | |
More InformationDrug Category: Antimalarial Used to treat: Malaria Report type*: Moderate Inhibitor |
|||
Vemuranfenib | CYP1A2 | View more Info | |
More InformationDrug Category: Chemotherapy Used to treat: Melanoma Report type*: Moderate Inhibitor |
|||
Dabrafenib | CYP3A | View more Info | |
More InformationDrug Category: Chemotherapy Used to treat: Melanoma, Braf-Mutated Cancers Report type*: Inducer |
|||
Olanzapine | CYP1A2 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Mental Disorders, Schizophrenia, And Bipolar Disorder Report type*: Genotype Impact |
|||
Haloperidol | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Mental Disorders, Symptoms Of Tourette Syndrome Report type*: Genotype Impact |
|||
Chlorpromazine | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Mental Illness, Behavioral Disorders, Nausea/Vomiting Report type*: Genotype Impact |
|||
Carisoprodol | CYP2C19 | View more Info | |
More InformationDrug Category: Neurological Drugs Used to treat: Muscle Relaxant Report type*: Genotype Impact |
|||
Aprepitant | CYP3A | View more Info | |
More InformationDrug Category: Antinausea/Antiemetic Used to treat: Nausea, Vomiting Report type*: Moderate Inhibitor |
|||
Ondansetron | CYP2D6 | View more Info | |
More InformationDrug Category: Antiemetic Used to treat: Nausea, Vomiting Report type*: Genotype Impact |
|||
Tropisetron | CYP2D6 | View more Info | |
More InformationDrug Category: Antiemetic Used to treat: Nausea, Vomiting Report type*: Genotype Impact |
|||
Dronabinol | CYP2C9 | View more Info | |
More InformationDrug Category: Antiemetic/Orexigenic Used to treat: Nausea, Vomiting / Loss Of Appetite, Weight Loss Report type*: Genotype Impact |
|||
Crizotinib | CYP3A | View more Info | |
More InformationDrug Category: Chemotherapy Used to treat: Non-Small Cell Lung Cancer Report type*: Moderate Inhibitor |
|||
Darifenacin | CYP2D6 | View more Info | |
More InformationDrug Category: Anticholinergics/Gu Used to treat: Overactive Bladder Report type*: Genotype Impact |
|||
Donepezil | CYP2D6 | View more Info | |
More InformationDrug Category: Anticholinesterases Used to treat: Overactive Bladder Report type*: Genotype Impact |
|||
Fesoterodine | CYP2D6 | View more Info | |
More InformationDrug Category: Anticholinergics/Gu Used to treat: Overactive Bladder Report type*: Genotype Impact |
|||
Galantamine | CYP2D6 | View more Info | |
More InformationDrug Category: Anticholinesterases Used to treat: Overactive Bladder Report type*: Genotype Impact |
|||
Mirabegron | CYP2D6 | View more Info | |
More InformationDrug Category: Overactive Bladder Used to treat: Overactive Bladder Report type*: Genotype Impact, Moderate Inhibitor |
|||
Tolterodine | CYP2D6 | View more Info | |
More InformationDrug Category: Anticholinergics/Gu Used to treat: Overactive Bladder Report type*: Genotype Impact |
|||
Celecoxib | CYP2C9 | View more Info | |
More InformationDrug Category: Nsaids/Gu Used to treat: Pain Report type*: Genotype Impact |
|||
Diclofenac | CYP2C9 | View more Info | |
More InformationDrug Category: Nsaids/Gu Used to treat: Pain Report type*: Genotype Impact |
|||
Flurbiprofen | CYP2C9 | View more Info | |
More InformationDrug Category: Nsaids Used to treat: Pain Report type*: Genotype Impact |
|||
Hydrocodone | CYP2D6 | View more Info | |
More InformationDrug Category: Opioid Analgesic Used to treat: Pain Report type*: Genotype Impact |
|||
Ibuprofen | CYP2C9 | View more Info | |
More InformationDrug Category: Nsaids Used to treat: Pain Report type*: Genotype Impact |
|||
Indomethacin | CYP2C9 | View more Info | |
More InformationDrug Category: Nsaids Used to treat: Pain Report type*: Genotype Impact |
|||
Mefenamic Acid | CYP2C9 | View more Info | |
More InformationDrug Category: Nsaids Used to treat: Pain Report type*: Genotype Impact |
|||
Meloxicam | CYP2C9 | View more Info | |
More InformationDrug Category: Nsaids Used to treat: Pain Report type*: Genotype Impact |
|||
Methadone | CYP2B6 | View more Info | |
More InformationDrug Category: Opoid Analgesics Used to treat: Pain Report type*: Genotype Impact |
|||
Morphine | OPRM1, COMT | View more Info | |
More InformationDrug Category: Opoid Analgesics Used to treat: Pain Report type*: Genotype Impact |
|||
Oxycodone | CYP2D6 | View more Info | |
More InformationDrug Category: Opioid Analgesic Used to treat: Pain Report type*: Genotype Impact |
|||
Piroxicam | CYP2C9 | View more Info | |
More InformationDrug Category: Nsaids Used to treat: Pain Report type*: Genotype Impact |
|||
Tramadol | CYP2D6 | View more Info | |
More InformationDrug Category: Opioid Analgesic Used to treat: Pain Report type*: Genotype Impact |
|||
Codeine | CYP2D6, OPRM1 | View more Info | |
More InformationDrug Category: Narcotic Used to treat: Pain, Cough Report type*: Genotype Impact |
|||
Tacrolimus | CYP3A5 | View more Info | |
More InformationDrug Category: Immunosuppressive Used to treat: Prevent Organ Rejection Post-Transplant Report type*: Genotype Impact |
|||
Cyclosporin | CYP3A | View more Info | |
More InformationDrug Category: Immunosuppressive Used to treat: Prevent Organ Rejection Post-Transplant, Rheumatoid Arthritis, Psoriasis, Chronic Dry Eye Report type*: Moderate Inhibitor |
|||
Clopidogrel | CYP2C19 | View more Info | |
More InformationDrug Category: Antiplatelet Drug (Blood Thinner) Used to treat: Prevention Of Stroke, Heart Attack Report type*: Genotype Impact |
|||
Ticlopidine | CYP2C19 | View more Info | |
More InformationDrug Category: Antiplatelet Drug (Blood Thinner) Used to treat: Prevention Of Stroke, Heart Attack Report type*: Strong Inhibitor |
|||
Abiraterone | CYP2D6 | View more Info | |
More InformationDrug Category: Chemotherapy Used to treat: Prostate Cancer Report type*: Moderate Inhibitor |
|||
Enzalutamide | CYP2C9, CYP2C19, CYP3A | View more Info | |
More InformationDrug Category: Nonsteroidal Antiandrogen Used to treat: Prostate Cancer Report type*: Inducer |
|||
Bosentan | CYP3A | View more Info | |
More InformationDrug Category: Dual Endothelin Receptor Antagonist Used to treat: Pulmonary Artery Hypertension Report type*: Inducer |
|||
Naltrexone | OPRM1 | View more Info | |
More InformationDrug Category: Alcohol/Drug Dependence Used to treat: Relapse Prevention Report type*: Genotype Impact |
|||
Clozapine | CYP1A2 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Schizophrenia Report type*: Genotype Impact |
|||
Iloperidone | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Schizophrenia Report type*: Genotype Impact |
|||
Thioridazine | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Schizophrenia Report type*: Genotype Impact |
|||
Perphenazine | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Schizophrenia, Nausea/Vomiting Report type*: Genotype Impact |
|||
Zuclopenthixol | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Schizophrenia, Psychoses Report type*: Genotype Impact |
|||
Brivaracetam | CYP2C19 | View more Info | |
More InformationDrug Category: Antiepileptic/Anticonvulsant Used to treat: Seizures/Epilepsy Report type*: Genotype Impact |
|||
Carbamazepine | CYP2C9, CYP2C19, CYP3A, CYP2B6 | View more Info | |
More InformationDrug Category: Antiepileptic/Anticonvulsant Used to treat: Seizures/Epilepsy Report type*: Inducer |
|||
Clobazam | CYP2C19 | View more Info | |
More InformationDrug Category: Benzodiazepine Used to treat: Seizures/Epilepsy Report type*: Genotype Impact |
|||
Lacosamide | CYP2C19 | View more Info | |
More InformationDrug Category: Antiepileptic/Anticonvulsant Used to treat: Seizures/Epilepsy Report type*: Genotype Impact |
|||
Phenobarbitone / Phenobarbital | CYP1A2, CYP2C9, CYP3A | View more Info | |
More InformationDrug Category: Antiepileptic/Anticonvulsant Used to treat: Seizures/Epilepsy Report type*: Inducer |
|||
Phenytoin | CYP2C9 / CYP1A2, CYP3A | View more Info | |
More InformationDrug Category: Antiepileptic/Anticonvulsant Used to treat: Seizures/Epilepsy Report type*: Genotype Impact, Inducer / Inducer |
|||
Primidone | CYP1A2, CYP2C9, CYP3A | View more Info | |
More InformationDrug Category: Antiepileptic/Anticonvulsant Used to treat: Seizures/Epilepsy Report type*: Inducer |
|||
Diazepam | CYP2C19 | View more Info | |
More InformationDrug Category: Benzodiazepine Used to treat: Seizures/Epilepsy, Anxiety, Muscle Spasms Report type*: Genotype Impact |
|||
Dapoxetine | CYP2D6 | View more Info | |
More InformationDrug Category: Sexual Dysfunction Used to treat: Sexual Dysfunction Report type*: Genotype Impact |
|||
Flibanserin | CYP2C19 | View more Info | |
More InformationDrug Category: Sexual Dysfunction Used to treat: Sexual Dysfunction Report type*: Genotype Impact |
|||
Pimozide | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Symptoms Of Tourette Syndrome Report type*: Genotype Impact |
|||
Pimozide | CYP2D6 | View more Info | |
More InformationDrug Category: Antipsychotic Used to treat: Symptoms Of Tourette Syndrome Report type*: Genotype Impact |
|||
Valbenazine | CYP2D6 | View more Info | |
More InformationDrug Category: Neurological Drugs Used to treat: Tardive Dyskinesia Report type*: Genotype Impact |
|||
Rifampicin | CYP1A2, CYP2C9, CYP2C19, CYP3A, CYP2B6 | View more Info | |
More InformationDrug Category: Antibiotic Used to treat: Tuberculosis Report type*: Inducer |
|||
Rifabutin | CYP2C9, CYP2C19, CYP3A | View more Info | |
More InformationDrug Category: Antibiotic Used to treat: Tuberculosis And Mycobacterium Avium Complex Prevention Report type*: Inducer |
|||
Glibenclamide | CYP2C9 | View more Info | |
More InformationDrug Category: Antidiabetic Used to treat: Type 2 Diabetes Report type*: Genotype Impact |
|||
Gliclazide | CYP2C9, CYP2C19 | View more Info | |
More InformationDrug Category: Antidiabetic Used to treat: Type 2 Diabetes Report type*: Genotype Impact |
|||
Glimepiride | CYP2C9 | View more Info | |
More InformationDrug Category: Antidiabetic Used to treat: Type 2 Diabetes Report type*: Genotype Impact |
|||
Glipizide | CYP2C9 | View more Info | |
More InformationDrug Category: Antidiabetic Used to treat: Type 2 Diabetes Report type*: Genotype Impact |
|||
Glyburide | CYP2C9 | View more Info | |
More InformationDrug Category: Antidiabetic Used to treat: Type 2 Diabetes Report type*: Genotype Impact |